
Epsilogen buys rival cancer antibody firm TigaTx
UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies. Epsilogen rose to prominence a few years ago by becoming the first biotech to start clinical …